Sihtasutus Parnu Haigla
- Address
- lock Available on a paid plan
Sihtasutus Parnu Haigla - Multi-Specialty Clinical Research Center
Sihtasutus Parnu Haigla is a clinical research center with expertise spanning multiple therapeutic areas including infectious diseases, gastroenterology, and critical care medicine. The center demonstrates capability in conducting diverse clinical trials from early efficacy assessments to large-scale comparative effectiveness studies.
- Respiratory infections and pneumonia management with focus on mortality reduction and clinical outcomes
- Inflammatory bowel diseases including ulcerative colitis with expertise in biologic therapy evaluation
- Complicated urinary tract infections and acute pyelonephritis utilizing both oral and intravenous antibiotic regimens
The research center has participated in significant studies including the RECOVERY trial for pneumonia treatment protocols, advanced immunotherapy investigations for ulcerative colitis, and comparative antibiotic efficacy trials for complicated urinary tract infections. Their experience encompasses Phase 3 studies with sophisticated endpoints including clinical cure rates, microbiological eradication, and disease activity assessments, demonstrating comprehensive capabilities in patient care monitoring and data collection across multiple disease states.
Site Overview
Activity Indicator
Last 6 months
Trial Flow
How this site's trials are distributed across therapeutic areas and active substances (IMPs), and how they're positioned within their overall lifecycle status. Flow thickness represents the number of unique trials.
Top 5 therapeutic areas and 15 of 24 IMPs, ranked by number of trials.
Compounds & Molecules Timeline
The time span of clinical-trial activity for the main active substances (IMPs) studied at this site over the last 8 years. Each bar runs from the earliest trial start to the most recent end; a substance with a trial still open has no recorded end and is shown as ongoing.
Sponsor & Partnership
Top sponsors by active trials, and the ones that have come back for more than one study.
Sponsor Network
Top 3 by active trials.
- 1AbbVie Deutschland GmbH & Co. KG1active
lock +2 more on a paid plan
Partnership History
Sponsors with repeated collaboration (≥ 2 trials).
- 1AbbVie Deutschland GmbH & Co. KG2trials
Sponsor Network Graph
How sponsors and therapeutic areas connect across this site's active trials: each link is at least one active trial shared between them, and bigger nodes mean more activity. Click a node to see its exact connections.
Country Benchmark
Compared to 44 other sites in Estonia
Therapeutic Area Benchmark — Estonia
Select a therapeutic area to compare against other sites in Estonia.
Competitor Comparison
Similar sites in the same country running a comparable number of trials (within ±30%), scored on how closely their trial portfolios match this one. Higher percentages mean a more similar profile.
Country: Estonia
Market Share
Country: Estonia
Therapeutic Area Market Share
Select a therapeutic area to view its disease coverage breakdown.
Heat Maps & Advanced Analytics
How often specific conditions appear in trials across this site and comparable sites from the same country. Each row is a site, each column a condition, and each cell the number of trials on it — darker means more activity.
Other Trials in Sihtasutus Parnu Haigla
lock Showing 1 of 5 trials — the rest is available on a paid plan.
| Trial | Sponsor | Phase | Status | Start Date | End Date |
|---|---|---|---|---|---|
| Comparative Efficacy and Safety of Risankizumab Versus Vedolizumab in Adult Patients With Moderate to Severe Ulcerative Colitis Naïve to Targeted Therapies | AbbVie Deutschland GmbH & Co. KG | Phase III | Not Recruiting | Jul 2025 | — |
IMP list
lock Showing 1 of 24 compounds — the rest is available on a paid plan.
| IMP | Trials | Status | First start | Last start |
|---|---|---|---|---|
| Prednisolone | 2 | Unknown | 2024-02-29 | 2026-03-24 |
Upgrade this site to Business Plan
Own the profile, publish your feasibility data and reach sponsors directly.
Is something out of date?
Tell us what needs correcting and we'll update this profile.
lock Available to Business plan sites only.